Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 4;29(8):1161-1180.
doi: 10.1016/j.stem.2022.07.006.

Wound healing, fibroblast heterogeneity, and fibrosis

Affiliations
Review

Wound healing, fibroblast heterogeneity, and fibrosis

Heather E Talbott et al. Cell Stem Cell. .

Abstract

Fibroblasts are highly dynamic cells that play a central role in tissue repair and fibrosis. However, the mechanisms by which they contribute to both physiologic and pathologic states of extracellular matrix deposition and remodeling are just starting to be understood. In this review article, we discuss the current state of knowledge in fibroblast biology and heterogeneity, with a primary focus on the role of fibroblasts in skin wound repair. We also consider emerging techniques in the field, which enable an increasingly nuanced and contextualized understanding of these complex systems, and evaluate limitations of existing methodologies and knowledge. Collectively, this review spotlights a diverse body of research examining an often-overlooked cell type-the fibroblast-and its critical functions in wound repair and beyond.

Keywords: fibroblast heterogeneity; fibroblasts; fibrosis; regeneration; wound healing.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests M.T.L. is co-founder of, has an equity position in, and is on the Board of Directors of Neodyne Biosciences, Inc., which developed the embrace device. M.T.L., S.M., and H.E.T. are inventors on patent 62/879,369 held by Stanford University that covers use of YAP inhibition for wound healing and patent application PCT/US2020/043,717 that covers a machine-learning algorithm for analysis of connective tissue networks in scarring and chronic fibroses.

Figures

Figure 1:
Figure 1:. Differences in the architecture of mouse versus human skin.
A) Depiction of mouse skin structure, which includes a panniculus carnosus (PC) muscle layer under the hypodermis. B) Depiction of human skin structure. Human skin differs from mouse skin in that it is thicker overall, has sparser hair follicles (HF), and contains eccrine sweat glands (ESG) which are not found in mice outside the skin of the paws. For both mouse and human skin schematics, various mesenchymal subpopulations and characteristic markers are shown, including microanatomically defined fibroblast lineages (papillary, reticular, hypodermal fibroblasts), functionally defined fibroblast lineages (Engrailed-1 lineage-positive and lineage-negative fibroblasts), HF-associated fibroblasts (dermal sheath, papilla, arrector pili), and pericytes. SG, sebaceous gland; DWAT, dermal white adipose tissue; APM, arrector pili muscle.
Figure 2:
Figure 2:. Fibroblast heterogeneity in mouse skin wound healing.
Left: Heterogeneous responses to wounding for the three microanatomically-defined lineages of fibroblasts (papillary, reticular, hypodermal). In small wounds, reticular (middle) and hypodermal (bottom) lineages dominate, giving rise to scarring myofibroblasts. In larger wounds (e.g., WIHN), papillary fibroblasts (top) preferentially interact with epidermal elements to drive sparse adnexal regeneration, and a subset of reticular layer-derived myofibroblasts regenerates adipocytes. Pericytes (bottom middle) and possibly circulating hematopoietic cells (“fibrocytes”, top middle) may also generate scarring myofibroblasts. Right: Heterogeneity in wound healing responses by Engrailed-1 (En-1) lineage-positive (green, EPF) and -negative (red, ENF) fibroblasts. EPFs are responsible for the vast majority of dorsal skin scarring in response to wounding, while ENFs do not contribute to fibrosis; a subset of ENFs reactivates En-1 to contribute postnatally-derived scarring EPFs. Proposed sources of scarring EPFs include the dermis (all layers), adipose tissue, circulating cells, and fascia. How these different lineages of fibroblasts (papillary, reticular, adipose, EPFs/ENFs, etc.) overlap and/or give rise to one another remains unclear.
Figure 3:
Figure 3:. Levels of molecular regulation of fibroblast behavior.
Fibroblast behavior depends on the complex interplay of many factors, including these cells’ epigenomic, transcriptomic, and proteomic profiles. Modern technologies are able to interrogate fibroblasts at each of these molecular levels to better understand fibroblast heterogeneity and functioning.
Figure 4:
Figure 4:. Mechanisms of mechanotransduction signaling.
Schematic depicting the diverse mechanisms and signaling pathways/cascades by which fibroblasts and other mechanosensitive cell types may communicate changes in their mechanical environment to molecular phenotypic changes. Multiple levels of evidence exist to show that fibroblasts activate pro-fibrotic machinery in response to mechanical stress, and that fibroblast mechanical signaling can be targeted to mitigate fibrosis.

References

    1. Aarabi S, Bhatt KA, Shi Y, Paterno J, Chang EI, Loh SA, Holmes JW, Longaker MT, Yee H, and Gurtner GC (2007). Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 21, 3250–3261. 10.1096/fj.07-8218com. - DOI - PubMed
    1. Abbasi S, Sinha S, Labit E, Rosin NL, Yoon G, Rahmani W, Jaffer A, Sharma N, Hagner A, Shah P, et al. (2020). Distinct Regulatory Programs Control the Latent Regenerative Potential of Dermal Fibroblasts during Wound Healing. Cell Stem Cell 27, 396–412 e396. 10.1016/j.stem.2020.07.008. - DOI - PubMed
    1. Abe R, Donnelly SC, Peng T, Bucala R, and Metz CN (2001). Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166, 7556–7562. 10.4049/jimmunol.166.12.7556. - DOI - PubMed
    1. Ali SR, Ranjbarvaziri S, Talkhabi M, Zhao P, Subat A, Hojjat A, Kamran P, Muller AM, Volz KS, Tang Z, et al. (2014). Developmental heterogeneity of cardiac fibroblasts does not predict pathological proliferation and activation. Circulation research 115, 625–635. 10.1161/CIRCRESAHA.115.303794. - DOI - PubMed
    1. Angelini A, Trial J, Ortiz-Urbina J, and Cieslik KA (2020). Mechanosensing dysregulation in the fibroblast: A hallmark of the aging heart. Ageing Res Rev 63, 101150. 10.1016/j.arr.2020.101150. - DOI - PMC - PubMed

Publication types

LinkOut - more resources